ANI Pharmaceuticals Files 8-K

Ticker: ANIP · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1023024

Ani Pharmaceuticals Inc 8-K Filing Summary
FieldDetail
CompanyAni Pharmaceuticals Inc (ANIP)
Form Type8-K
Filed DateJul 29, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

ANI Pharma filed an 8-K, something happened, details TBD.

AI Summary

ANI Pharmaceuticals, Inc. filed an 8-K on July 29, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or definitive dates beyond the report date itself. The company's principal executive offices are located at 210 Main Street West, Baudette, Minnesota.

Why It Matters

This filing indicates a material event has occurred for ANI Pharmaceuticals, Inc., requiring public disclosure, though the specifics are not yet detailed.

Risk Assessment

Risk Level: medium — The filing of an 8-K signals a significant event, but the lack of detail in this specific filing creates uncertainty about the nature and impact of the event.

Key Players & Entities

  • ANI Pharmaceuticals, Inc. (company) — Registrant
  • July 29, 2025 (date) — Date of Report
  • 210 Main Street West, Baudette, Minnesota (location) — Principal executive offices
  • BIOSANTE PHARMACEUTICALS INC (company) — Former company name
  • BEN ABRAHAM TECHNOLOGIES INC (company) — Former company name

FAQ

What specific event is reported in this 8-K filing by ANI Pharmaceuticals, Inc.?

The filing is categorized under 'Other Events' and does not provide specific details about the event itself.

When was this 8-K report filed by ANI Pharmaceuticals, Inc.?

The report was filed on July 29, 2025.

Where are the principal executive offices of ANI Pharmaceuticals, Inc. located?

The principal executive offices are located at 210 Main Street West, Baudette, Minnesota, 56623.

Has ANI Pharmaceuticals, Inc. operated under any former names?

Yes, the company was formerly known as BIOSANTE PHARMACEUTICALS INC and BEN ABRAHAM TECHNOLOGIES INC.

What is the Commission File Number for ANI Pharmaceuticals, Inc.?

The Commission File Number for ANI Pharmaceuticals, Inc. is 001-31812.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.